Tian-zhi Tan

Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor

Yunchun Li, An'ren Kuang, Lin He, 2005, Cancer Gene Therapy.

Anti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties.

Tian-zhi Tan, Yun-chun Li, Jian-guo Zheng, 2008, World journal of gastroenterology.

Biodistribution and localization of iodine-131 labeled metuximab in patients with hepatocellular carcinoma

Min Zhang, Yang Zhang, P. Zhu, 2006, Cancer Biology & Therapy.

131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR.

Sheng He, Tian-zhi Tan, Y. Li, 2004, Nuclear medicine and biology.

Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect.

Zhenglun Liang, An'ren Kuang, Tian-zhi Tan, 2002, Chinese Medical Journal.

Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.

Jing Xu, Ping Zhu, Nan Leng, 2006, International journal of radiation oncology, biology, physics.

Antisense imaging of colon cancer-bearing nude mice with liposome-entrapped 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA.

Tian-zhi Tan, Jian-guo Zheng, 2004, World journal of gastroenterology.

[Preparation of liposome-mediated 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA].

Zhenglun Liang, Yunchun Li, Tian-zhi Tan, 2003, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi.